United Kingdom· GB-APID-45154211000001100
Omvoh 200mg/2ml solution for injection pre-filled pens
A mirikizumab product containing mirikizumab, registered in United Kingdom by Eli Lilly and Company Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mirikizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AC24 (mirikizumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Mirikizumab · ATC L04AC24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirikizumab costs, country by country.
Normalised to the WHO defined daily dose (7.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mirikizumab · price per daily dose (7.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$30.99
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mirikizumab
- Manufacturer
- Eli Lilly and Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AC24
- ATC class
- Mirikizumab
- Defined daily dose
- 7.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirikizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOMVOHEli Lilly Nederland B.V., Utrecht
- BelgiumOmvoh 100 mgEli Lilly Nederland
- SwedenOmvoh 100 mg + 200 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- SwitzerlandOmvoh 100 mg + 200 mg, solution injectable en seringue préremplieEli Lilly (Suisse) SA
- SpainOMVOH 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAEli Lilly Nederland B.V.
- IcelandOmvohEli Lilly Nederland B.V.*
- NorwayOmvohEli Lilly Nederland B.V.
- United StatesOmvohEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Omvoh
- Liechtenstein · Omvoh
- Norway · Omvoh
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f93a9467-975d-4f50-ba69-878de922aa92 GET /v1/drugs/f93a9467-975d-4f50-ba69-878de922aa92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45154211000001100",
"desc": "Omvoh 200mg/2ml solution for injection pre-filled pens (Eli Lilly and Company Ltd)",
"form": "Solution for injection",
"vpid": "45294711000001103",
"source": "dmd",
"vtm_id": "42027611000001104",
"strength": "100 mg",
"substance": "Mirikizumab",
"ingredient": "Mirikizumab",
"supplier_code": "2075101000001100"
}See everything about mirikizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.